These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 18239805)
1. A comparative study of stimulation of erythropoiesis during renal anemia with the preparation of antibodies against erythropoietin in ultralow doses and Recormon. Epshtein OI; Dygai AM; Zhdanov VV; Sergeeva SA; Zyuz'kov GN; Udut EV; Khrichkova TY; Simanina EV; Gur'yantseva LA; Stavrova LA; Gol'dberg ED Bull Exp Biol Med; 2007 Jun; 143(6):699-702. PubMed ID: 18239805 [TBL] [Abstract][Full Text] [Related]
2. Specific activities of poetam preparation (superlow-doses of antibodies to erythropoietin) and recombinant erythropoietin. Dygai AM; Zhdanov VV; Udut EV; Simanina EV; Gur'yantseva LA; Khrichkova TY; Epshtein OI; Sergeeva SA Bull Exp Biol Med; 2006 Sep; 142(3):320-3. PubMed ID: 17426839 [TBL] [Abstract][Full Text] [Related]
3. [The recovery of erythropoiesis after the short-term Recormon treatment of renal anemia]. Nikolaev AIu; Klepikov PV; Lashutin SV Ter Arkh; 1992; 64(6):90-1. PubMed ID: 1440349 [No Abstract] [Full Text] [Related]
4. Mechanisms of Erythropoietin-Stimulating Action of Anti-Erythropoietin Release-Active Antibodies in Complex Treatment of Experimental Anemia during Gestation. Burmina YV; Udut EV; Zhdanov VV; Sotnikova LS; Miroshnichenko LA; Simanina EV; Polyakova TY; Zyuz'kov GN; Chaikovskii AV; Stavrova LA; Epshtein OI; Dygai AM Bull Exp Biol Med; 2016 Apr; 160(6):737-41. PubMed ID: 27165080 [TBL] [Abstract][Full Text] [Related]
5. Erythropoietic activity of preparations containing receptors and antibodies to erythropoietin in ultralow doses. Zhdanov VV; Simanina EV; Dugina YL; Stavrova LA; Gur'yantseva LA; Epstein OI; Dygai AM; Goldberg ED Bull Exp Biol Med; 2003 Jan; 135 Suppl 7():73-4. PubMed ID: 12949657 [TBL] [Abstract][Full Text] [Related]
6. Potentiation of the stimulatory effect of erythropoietin on erythropoiesis by antiserotonin drug during cytostatic myelosuppression. Goldberg ED; Dygai AM; Skurikhin EG; Pershina OV; Minakova MY; Ermakova NN; Firsova TV Bull Exp Biol Med; 2009 Jul; 148(1):45-8. PubMed ID: 19902094 [TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of desferrioxamine and recombinant erythropoietin on erythroid precursor proliferation in chronic renal failure. Aucella F; Vigilante M; Scalzulli P; Musto P; Prencipe M; Valente GL; Carotenuto M; Stallone C Nephrol Dial Transplant; 1999 May; 14(5):1171-5. PubMed ID: 10344357 [TBL] [Abstract][Full Text] [Related]
8. Assessing erythropoiesis and the effect of erythropoietin therapy in renal disease by reticulocyte counting. Pradella M; Cavill I; d'Onofrio G Clin Lab Haematol; 1996 Dec; 18 Suppl 1():35-7. PubMed ID: 9054717 [TBL] [Abstract][Full Text] [Related]
9. [Individual differences in the efficacy of Recormon in patients with terminal kidney failure. The role of iron deficiency]. Nikolaev AIu; Klepikov PV; Lashutin SV; Kondakhchan MA; Rogov VA; Trofimova EI Ter Arkh; 1993; 65(6):45-8. PubMed ID: 8378849 [TBL] [Abstract][Full Text] [Related]
11. [Current issues in erythropoietin therapy of renal anemia]. Zakar G Lege Artis Med; 2007 Oct; 17(10):667-73. PubMed ID: 19227596 [TBL] [Abstract][Full Text] [Related]
12. [COMPARATIVE ANALYSIS OF REPOA (EPOKRIN) AND REPOB (RECORMON) INFLUENCE ON ERYTHROPOIESIS IN VIVO AND IN VITRO]. Tishevskaya NV Eksp Klin Farmakol; 2016; 79(2):24-8. PubMed ID: 27416679 [TBL] [Abstract][Full Text] [Related]
13. Erythropoietic action of dexamethasone on the anemia associated with an experimental chronic renal failure. Malgor LA; Barrios L; de Albarenque MV; Verges E; de Markowsky EE; Montiel E; Mussin SM Acta Physiol Pharmacol Latinoam; 1987; 37(3):365-76. PubMed ID: 3503475 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the responses to recombinant human erythropoietin in normal and uremic subjects. Eschbach JW; Haley NR; Egrie JC; Adamson JW Kidney Int; 1992 Aug; 42(2):407-16. PubMed ID: 1405323 [TBL] [Abstract][Full Text] [Related]
15. Pathogenetic Evaluation of Dysfunction in the Erythron System of Experimental Animals during Modeling of Iron Deficiency Anemia in the Gestation Period. Zhdanov VV; Udut EV; Sotnikova LS; Burmina YV; Miroshnichenko LA; Simanina EV; Polyakova TY; Zyuz'kov GN; Chaikovskii AV; Stavrova LA; Fedorova EP; Dygai AM Bull Exp Biol Med; 2016 Feb; 160(4):417-20. PubMed ID: 26902349 [TBL] [Abstract][Full Text] [Related]
16. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure. Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177 [TBL] [Abstract][Full Text] [Related]
17. [Anemia of chronic renal failure: erythropoiesis and serum inhibitor(s) of erythroid progenitor cells in uremia]. Urushiyama M; Moriyama Y Rinsho Ketsueki; 1985 May; 26(5):668-73. PubMed ID: 4057581 [No Abstract] [Full Text] [Related]
19. Erythropoietic effects of triiodothyronine on the anemia of renal failure in rats: comparative studies with testosterone and erythropoietin. Malgor LA; Barrios L; de Albarenque ME; Verges E; de Markowsky EE; Montiel E; Mussin SM Exp Hematol; 1986 May; 14(4):250-6. PubMed ID: 3699108 [TBL] [Abstract][Full Text] [Related]